Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Epicur Pharma® Continues Namesake Sponsorship for the 2025 ACVO®/Epicur Service Animal Volunteer Eye Screening (ACVO®-SAVES™)


News provided by

Epicur Pharma

Mar 25, 2025, 14:30 ET

Share this article

Share toX

Share this article

Share toX

Epicur is the official namesake sponsor of the 2025 ACVO-SAVES event
Epicur is the official namesake sponsor of the 2025 ACVO-SAVES event

Epicur Pharma® is thrilled to announce its continued namesake sponsorship of the ACVO®/Epicur Service Animal Volunteer Eye Screening (ACVO-SAVES) for the 2025 event. Epicur has been a dedicated supporter of this remarkable event since 2014 and has secured the bid to be the official namesake sponsor of the ACVO-SAVES event through 2027.

MOUNT LAUREL, N.J., March 25, 2025 /PRNewswire-PRWeb/ -- Epicur Pharma® is thrilled to announce its continued namesake sponsorship of the ACVO®/Epicur Service Animal Volunteer Eye Screening (ACVO-SAVES) for the 2025 event. Epicur has been a dedicated supporter of this remarkable event since 2014 and has secured the bid to be the official namesake sponsor of the ACVO-SAVES event through 2027.

Formerly known as the ACVO/Epicur National Service Animal Eye Exam Event, this philanthropic event is held annually in May to provide free, sight-saving screening eye exams to Service and Working Animals across the globe. The exams are provided by the board-certified Diplomates of the American College of Veterinary Ophthalmologists (ACVO) who volunteer their time and expertise to ensure that these incredible animals maintain good eye health.

Our dedication to excellence in veterinary medicine aligns seamlessly with the mission of this event, ensuring that these exceptional animals receive the highest standard of care to continue their important work.

Post this

From guiding individuals with visual impairments to assisting in search and rescue operations, Service and Working Animals have crucial jobs, and their eye health is vital to their ability to perform these essential tasks. The ACVO-SAVES event allows handlers to secure a baseline of eye health for their animals and exemplifies the heart of the veterinary industry. Now in its 15th year, ACVO's volunteer Diplomates have provided approximately 86,000 complimentary eye screenings throughout the USA, Canada, Hong Kong, Puerto Rico, and the UK since its first year. During last year's event, over 5,500 animals received free eye exams thanks to the dedication of 265 ACVO Diplomates who volunteered their time and resources.

"Epicur Pharma is honored to extend our continued support for the ACVO/Epicur Service Animal Volunteer Eye Screening Event. We are deeply committed to advancing the health and well-being of animals, and we recognize the vital role that early detection and treatment of eye conditions play in the long-term care of Service and Working Animals. Our dedication to excellence in veterinary medicine aligns seamlessly with the mission of this event, ensuring that these exceptional animals receive the highest standard of care to continue their important work," said Michael Tursi, President of Epicur Pharma.

ACVO Executive Director Stacee Daniel said, "The ACVO is honored to accept the three-year sponsorship bid from Epicur in support of the ACVO-SAVES program. It is apparent that Epicur's consistent dedication and active involvement in this philanthropic event have been a long-standing priority for the company. Our Diplomates enjoy Epicur's contributions to the program and respect their deep connection with the Service and Working Animal community. ACVO extends gratitude to Epicur for their generosity in supporting this fantastic program."

Registration for the 2025 ACVO/Epicur Service Animal Volunteer Eye Screening event is open April 1-30th. To find out if your service animal qualifies for the event, please visit https://www.acvoeyeexam.org/qualifications-expectations.

About Epicur Pharma:

Epicur Pharma®, a division of Stokes Healthcare, is an FDA Registered 503B Outsourcing Facility dedicated to manufacturing high-quality, compounded medications for veterinary use. Epicur Pharma is proud to be a pioneer in animal drug standards, offering one of the largest selections of manufactured drugs that are traditionally compounded. The Epicur brand of veterinary drug products ensures the highest quality backed by FDA oversight. Epicur products are being distributed directly to veterinary hospitals from its outsourcing facility and offered through Stokes Pharmacy for individual patient prescriptions. Visit www.epicurpharma.com to learn more.

About the American College of Veterinary Ophthalmologists (ACVO):

The ACVO® is an approved veterinary specialty organization of the American Board of Veterinary Specialties, dedicated to advancing the quality of veterinary medicine through certification of veterinarians who demonstrate excellence in veterinary ophthalmology. For more information, please visit www.ACVO.org.

Media Contact

Michael Tursi, Epicur Pharma, 1 856-208-7811, [email protected], https://epicurpharma.com/

SOURCE Epicur Pharma

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.